350 related articles for article (PubMed ID: 19266143)
21. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
22. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
Panegyres PK; Goh JG
J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
[TBL] [Abstract][Full Text] [Related]
23. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Dec; 50(6):373-80. PubMed ID: 11761463
[TBL] [Abstract][Full Text] [Related]
24. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
25. Basal ganglia-cortical structural connectivity in Huntington's disease.
Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
[TBL] [Abstract][Full Text] [Related]
26. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
[TBL] [Abstract][Full Text] [Related]
27. Structural brain correlates of dementia in Huntington's disease.
Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
[TBL] [Abstract][Full Text] [Related]
28. Excessive blinking as an initial manifestation of juvenile Huntington's disease.
Xing S; Chen L; Chen X; Pei Z; Zeng J; Li J
Neurol Sci; 2008 Sep; 29(4):275-7. PubMed ID: 18810605
[TBL] [Abstract][Full Text] [Related]
29. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
[TBL] [Abstract][Full Text] [Related]
30. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease.
Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
Exp Neurol; 2008 Sep; 213(1):137-44. PubMed ID: 18588876
[TBL] [Abstract][Full Text] [Related]
31. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; Piccini P
Hum Brain Mapp; 2011 Feb; 32(2):258-70. PubMed ID: 21229614
[TBL] [Abstract][Full Text] [Related]
32. Defective emotion recognition in early HD is neuropsychologically and anatomically generic.
Henley SM; Wild EJ; Hobbs NZ; Warren JD; Frost C; Scahill RI; Ridgway GR; MacManus DG; Barker RA; Fox NC; Tabrizi SJ
Neuropsychologia; 2008; 46(8):2152-60. PubMed ID: 18407301
[TBL] [Abstract][Full Text] [Related]
33. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
[TBL] [Abstract][Full Text] [Related]
34. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
[TBL] [Abstract][Full Text] [Related]
35. Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis.
Dogan I; Eickhoff SB; Schulz JB; Shah NJ; Laird AR; Fox PT; Reetz K
Neurodegener Dis; 2013; 12(1):23-35. PubMed ID: 22922585
[TBL] [Abstract][Full Text] [Related]
36. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Rising AC; Xu J; Carlson A; Napoli VV; Denovan-Wright EM; Mandel RJ
Exp Neurol; 2011 Apr; 228(2):173-82. PubMed ID: 21192926
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Huntington's disease CAG Repeat Length Stability in Human Motor Cortex and Cingulate Gyrus.
Geraerts FC; Snell RG; Faull RL; Williams L; Jacobsen JC; Reid SJ
J Huntingtons Dis; 2016 Oct; 5(3):297-301. PubMed ID: 27716680
[TBL] [Abstract][Full Text] [Related]
39. Early Neurodegeneration in R6/2 Mice Carrying the Huntington's Disease Mutation with a Super-Expanded CAG Repeat, Despite Normal Lifespan.
Kielar C; Morton AJ
J Huntingtons Dis; 2018; 7(1):61-76. PubMed ID: 29480204
[TBL] [Abstract][Full Text] [Related]
40. Clinical correlates of mitochondrial function in Huntington's disease muscle.
Turner C; Cooper JM; Schapira AH
Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
